Monoamine releasing agent Norepinephrine-dopamine releasing agent Serotonin-dopamine releasing agent Serotonin-norepinephrine- ... Many releasing agents of both dopamine and norepinephrine (norepinephrine-dopamine releasing agents, or NDRAs) and of serotonin ... serotonin-norepinephrine-dopamine releasing agents, or SNDRAs), however. Serotonin-dopamine releasing agents are much rarer and ... A dopamine releasing agent (DRA) is a type of drug which induces the release of dopamine in the body and/or brain. No selective ...

Monoamine releasing agent Media related to Norepinephrine-dopamine releasing agents at Wikimedia Commons v t e (Commons ... A norepinephrine-dopamine releasing agent (NDRA) is a type of drug which induces the release of norepinephrine (and epinephrine ... Norepinephrine-dopamine releasing agents, TAAR1 agonists, VMAT inhibitors, All stub articles, Pharmacology stubs). ... A closely related type of drug is a norepinephrine-dopamine reuptake inhibitor (NDRI). ...

Monoamine releasing agent Serotonin releasing agent Dopamine releasing agent Serotonin-norepinephrine-dopamine releasing agent ... A serotonin-dopamine releasing agent (SDRA) is a type of drug which induces the release of serotonin and dopamine in the body ... One such agent is 5-chloro-αMT (PAL-542), which has been reported as having about 64-fold selectivity for dopamine release over ... Another agent is 5-fluoro-αET (PAL-545), which has about 35-fold selectivity for dopamine release over norepinephrine release ...

Monoamine releasing agent Norepinephrine-dopamine releasing agent Serotonin-dopamine releasing agent Serotonin-norepinephrine ... A serotonin-norepinephrine-dopamine releasing agent (SNDRA), also known as a triple releasing agent (TRA), is a type of drug ... Media related to Serotonin-norepinephrine-dopamine releasing agents at Wikimedia Commons v t e (Articles with short description ... Short description matches Wikidata, Commons category link is on Wikidata, Serotonin-norepinephrine-dopamine releasing agents, ...

Dopamine releasing agents, Medical treatments). ... DRT increases dopamine in the brain to optimal levels in order ... Dopamine replacement therapy (DRT) is an effective treatment for patients with decreased levels of dopamine. Often dopamine ... Dopamine therapy is the regulation of levels of the neurotransmitter dopamine through the use of either agonists, or ... Impairment in these areas can be treated with dopamine agonists, a group of medications that mimics the ligand dopamine and ...

They are also similar to serotonin-norepinephrine-dopamine releasing agents (SNDRAs) like MDMA ("ecstasy") and α- ... Rothman, RB; Blough, BE; Baumann, MH (2008). "Dual dopamine/serotonin releasers: Potential treatment agents for stimulant ... Tetrabenazine, a similar agent to reserpine, which also depletes catecholamine stores, and to a lesser degree 5-HT, was shown ... A serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI), also known as a triple reuptake inhibitor (TRI), is a type of ...

de Paulis T (1983). "3. Antipsychotic Agents and Dopamine Agonists". Annual Reports in Medicinal Chemistry. Academic Press. p. ... Altar CA, Boyar WC, Wasley A, Gerhardt SC, Liebman JM, Wood PL (August 1988). "Dopamine neurochemical profile of atypical ... Flumezapine is an antipsychotic, due to its antagonism of dopamine receptors in the brain. However, like other antipsychotics, ... indicating higher dopamine receptor blockade with less anticholingergic properties. Flumezapine is a thioeno[2,3-b][1,5] ...

Joyce JN, Millan MJ (July 2005). "Dopamine D3 receptor antagonists as therapeutic agents". Drug Discovery Today. 10 (13): 917- ... SB-277,011A is a drug which acts as a potent and selective dopamine D3 receptor antagonist, which is around 80-100x selective ... Southam E, Lloyd A, Jennings CA, Cluderay JE, Cilia J, Gartlon JE, Jones DN (May 2007). "Effect of the selective dopamine D3 ... November 2002). "Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats". The ...

Townes S, Titone C, Rosenberg RC (February 1990). "Inhibition of dopamine beta-hydroxylase by bidentate chelating agents". ... dopamine beta-monooxygenase dopamine beta-hydroxylase membrane-associated dopamine beta-monooxygenase (MDBH) soluble dopamine ... Dopamine beta-hydroxylase (DBH), also known as dopamine beta-monooxygenase, is an enzyme (EC 1.14.17.1) that in humans is ... Dopamine beta-hydroxylase catalyzes the conversion of dopamine to norepinephrine. The three substrates of the enzyme are ...

Amphetamine is a norepinephrine-dopamine releasing agent (NDRA). It enters neurons through dopamine and norepinephrine ... and the dopamine transporter (DAT). Methylphenidate has a higher affinity for the dopamine transporter than for the ... and so its effects are mainly due to elevated dopamine levels caused by the inhibited reuptake of dopamine, however increased ... It may be used as a nasal/sinus decongestant, as a stimulant, or as a wakefulness-promoting agent. The salts pseudoephedrine ...

A closely related type of drug is a serotonin-dopamine releasing agent (SDRA). Relative to serotonin-norepinephrine-dopamine ... and inhibit the reuptake of dopamine alone. As a result, selective dopamine reuptake inhibitors (DRIs) are rare, and comparably ... A serotonin-dopamine reuptake inhibitor (SDRI) is a type of drug which acts as a reuptake inhibitor of the monoamine ... Based on its chemical structure, UWA-101 may actually also possess some activity as a releasing agent, and if so, unlike RTI-83 ...

A closely related type of drug is a norepinephrine-dopamine releasing agent (NDRA). Many NDRIs exist, including the following: ... A norepinephrine-dopamine reuptake inhibitor (NDRI) is a drug used for the treatment of clinical depression, attention deficit ... The drug acts as a reuptake inhibitor for the neurotransmitters norepinephrine and dopamine by blocking the action of the ... Monoamine reuptake inhibitor Dopamine reuptake inhibitor Norepinephrine reuptake inhibitor Stephen M. Stahl (2 March 2009). ...

Like amphetamines, cathinone and ephedrine, cathine acts as a norepinephrine releasing agent (NRA). It also acts as a dopamine ... Acts via D1/D2-Like Dopamine Receptors in the Nucleus Accumbens Shell". Frontiers in Neuroscience. 14: 572328. doi:10.3389/ ... releasing agent (DRA). Cathine is one of the four stereoisomers of phenylpropanolamine (PPA). The World Anti-Doping Agency's ...

It most likely acts primarily as a dopamine releasing agent. Its activity as a norepinephrine or serotonin releasing agent is ... and chemical perspectives on atypical agents targeting the dopamine transporter". Drug and Alcohol Dependence. 147: 1-19. doi: ...

It is uncertain whether bupropion is a norepinephrine-dopamine releasing agent. Pharmacological actions of bupropion, to a ... dopamine, serotonin, histamine, and muscarinic acetylcholine receptors. The occupancy of dopamine transporter (DAT) by ... However, it is thought to be related to the fact that bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI) and ... In accordance with its low DAT occupancy, no measurable dopamine release in the human brain was detected with bupropion (one ...

... it is a serotonin-norepinephrine-dopamine releasing agent (SNDRA). In addition to actions at the monoamine transporters, 6-APB ... Serotonin-norepinephrine-dopamine releasing agents, Serotonin receptor agonists, Entactogens and empathogens). ... In addition, 6-APB not only blocks the reuptake of these monoamine neurotransmitters but is also a releasing agent of them; ... 6-APB and its structural isomer 5-APB have been tested with a series of agents including: Marquis, Liebermann, Mecke, and ...

... and dopamine (that is, it is an SNDRATooltip serotonin-norepinephrine-dopamine releasing agent). It is also an agonist of the ... In its pharmacology, MDA is a serotonin-norepinephrine-dopamine releasing agent (SNDRA). In most countries, the drug is a ... Serotonin-norepinephrine-dopamine releasing agents, Serotonin receptor agonists, Stimulants, Substituted amphetamines, TAAR1 ... release of dopamine and norepinephrine is responsible for its psychostimulant effects, dopamine release is necessary for its ...

It acts as a serotonin-norepinephrine-dopamine releasing agent (SNDRA), with EC50 values for induction of monoamine release of ... The 2,3-methyl and 4-methyl analogues show diminished activity as dopamine releasing agents with respective EC50 values of ... Serotonin-norepinephrine-dopamine releasing agents, Stimulants, All stub articles, Psychoactive drug stubs). ... and chemical perspectives on atypical agents targeting the dopamine transporter". Drug Alcohol Depend. 147: 1-19. doi:10.1016/j ...

... fails to reverse reserpine-induced akinesia, whereas dextroamphetamine, a dopamine releasing agent (DRA), is able to ... February 2015). "Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter". Drug ... Of the sites tested, it was found to significantly affect only the dopamine transporter (DAT), acting as a dopamine reuptake ... March 2009). "Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications". JAMA ...

Gylys JA, Wright RN, Nicolosi WD, Buyniski JP, Crenshaw RR (March 1988). "BMY-25801, an antiemetic agent free of D2-dopamine ...

... and chemical perspectives on atypical agents targeting the dopamine transporter". Drug and Alcohol Dependence. 147: 1-19. doi: ... atypical blocker of the dopamine transporter (and hence as a dopamine reuptake inhibitor), and this action may explain some or ... Additionally, the medication has been used non-medically as a novel vigilance-promoting agent. Adrafinil is a prodrug; it is ... Adrafinil is a wakefulness-promoting agent and was used to promote alertness, attention, wakefulness, and mood. It was ...

Serotonin-dopamine releasing agent (SDRA) Serotonin-norepinephrine-dopamine releasing agent (SNDRA) MRAs cause the release of ... Dopamine releasing agent (DRA) Non-selective, releasing two or more neurotransmitters Norepinephrine-dopamine releasing agent ( ... Dopamine releasing agents, usually selective for both norepinephrine and dopamine have psychostimulant effect, causing an ... Less selective serotonergic agents that stimulate an efflux in dopamine, such as MDMA are described as more pleasant, ...

Pharmacologically, MDMA acts as a serotonin-norepinephrine-dopamine releasing agent and reuptake inhibitor.[citation needed] de ...

MDEA acts as a serotonin, norepinephrine, and dopamine releasing agent and reuptake inhibitor. Possession of MDEA is illegal in ... Serotonin-norepinephrine-dopamine releasing agents, Substituted amphetamines). ...

PPA acts primarily as a selective norepinephrine releasing agent. It also acts as a dopamine releasing agent with around 10- ... Dopamine-β-hydroxylase catalyzed the removal of the pro-R hydrogen atom and the production of 1-norephedrine, (2S,1R)-2-amino-1 ... Agents such as metaraminol exhibit a greater degree of indirect sympathomimetic activity. Substitution on the β-Carbon Atom ... The metabolism of p-OHA to p-OHNor is well documented and dopamine-β hydroxylase present in noradrenergic neurons could easily ...

... acts as a serotonin-norepinephrine-dopamine reuptake inhibitor and a serotonin releasing agent. Pentylone is banned ... Serotonin-norepinephrine-dopamine reuptake inhibitors, Serotonin releasing agents, Stimulants, All stub articles, Nervous ...

... is a releasing agent and reuptake inhibitor of dopamine, serotonin, and norepinephrine. The respective EC50 ... The dopamine reuptake inhibition produced by 4-FA is stronger than that of either 4-CA or 4-IA. 4-FA also produces less ... since PAL-287 was reported to be not at all neurotoxic even though it is a powerful 5-HT releasing agent. It is unclear where 4 ... "p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent". European Journal of Pharmacology. 229 (1): ...

... (Chlorphencyclan; Tonquil, Vesitan) is a dopamine-releasing agent developed by Boehringer & Soehne in the 1950s. ... Norepinephrine-dopamine releasing agents, Diethylamino compounds, All stub articles, Nervous system drug stubs). ...

... is an anorectic drug which acts as a norepinephrine-dopamine releasing agent (NDRA). As an amphetamine congener ... Phendimetrazine possesses preferable pharmacokinetics over phenmetrazine as a therapeutic agent because its metabolization by ...

... and in animals the medication appears to act as a dopamine reuptake inhibitor and releasing agent. By increasing dopamine ... Pemoline is a psychostimulant and acts as a selective dopamine reuptake inhibitor and releasing agent. Hence, it functions as ... Pemoline is described as a selective dopamine reuptake inhibitor that only weakly stimulates dopamine release. While drugs like ... Norepinephrine-dopamine releasing agents, Oxazolidinones, Stimulants, Substances discovered in the 1910s, Withdrawn drugs). ...